시장보고서
상품코드
2117024

분자 접착제 시장 : 제품별, 용도별, 종류별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Molecular Glues Market, By Product, By Application, By Type, By End User, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 298 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,460,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,259,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 7,755,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

분자 접착제 시장 규모는 2025년에 42억 30만 달러로 평가되며, 2026년부터 2033년까지 CAGR 6.9%로 확대될 것으로 전망됩니다.

분자 접착제란 E3 유비퀴틴 리가아제에 결합하여 이를 서로 다른 단백질 기질로 유도함으로써, 유비퀴틴화와 분해를 유도하는 저분자 화합물입니다. 기존에 상용화가 진행 중인 제품은 레날리도마이드, 살리도마이드, 포말리도마이드 등의 면역 조절 이미드계 약물을 중심으로 구성되어 있지만, 신약 개발 단계에 있는 분자들은 CRBN, DCAF15, 그리고 최근에는 표적 및 경로에 기반한 리가아제 개발에 초점을 맞추고 있습니다. 상용화 노력은 종양학 분야가 주도하고 있으며, 면역학 및 기타 질병 영역이 기회의 폭을 넓히고 있습니다. 2025년 'Nature Communications'에 게재된 연구에 따르면, IMiD가 290종 이상의 고유한 단백질을 CRBN으로 동원하는 것이 입증되었으며, 그 중에는 확립된 표적 목록에 포함되지 않은 것들도 몇 가지 포함되어 있었습니다. 그 결과, 플랫폼의 발견, 선택성, 임상적으로 관련성이 높은 분해 메커니즘 등 이러한 도구에 대한 수요가 증가하고 있습니다.

분자 접착제 시장 - 시장 역학

기존에 신약 개발이 어렵다고 여겨졌던 단백질 영역의 확대

이 시장의 주요 차별화 요인은 분자 접착제가 표적 결합 포켓에 대한 요구 사항을 최소화하면서, 소분자가 내인성 유비퀴틴 리가제를 유도할 수 있도록 하는 협력적인 단백질 상호작용을 활용함으로써, 억제제가 아닌 분해제로서 치료가 어려운 단백질에 작용할 수 있다는 점에 있습니다. 이를 통해 표현형 스크리닝, 단백질체학 분석, 구조 생물학 및 AI를 활용한 기질 발견을 촉진하는, 근본적으로 다른 신약 개발 경제성이 창출됩니다. 2025년 Monte Rosa사가 자사의 QuEEN 신약 개발 엔진을 사용하여 실시한 인실리코 분석에 따르면, 적어도 1,600종류의 서로 다른 단백질이 세레브론을 통해 표적화될 수 있는 것으로 나타났으며, 이는 분자 접착제 분해제에 있어 표적 영역의 다양성이 매우 크다는 것을 시사합니다. 따라서 선택적인 네오 기질을 식별할 수 있는 신약 개발 플랫폼이 파이프라인을 결정짓는다는 사실이 점차 명확해지고 있습니다.

분자 접착제 시장 - 시장 세분화 분석:

세계 분자 접착제 시장은 제품, 용도, 유형, 최종사용자 및 지역을 기준으로 세분화되어 있습니다.

레날리도마이드, 살리도마이드, 포말리도마이드는 주요 제품 부문이며, 이에 대한 임상 검증을 통해 세라브론을 매개로 한 분해가 치료법으로서 가치를 지닌다는 것이 입증되었습니다. 레날리도마이드와 포마리도마이드는 레날리도마이드와 유사한 ‘분자 접착제’의 단점을 유발할 가능성이 크기 때문에 차세대 분해 분자 개발에서 우선적으로 고려되는 선도 화합물이 되었습니다. 그러나 살리도마이드가 여전히 작용 기전을 설명하는 데 기초가 되는 중요한 기준 화합물로 남아 있습니다. 제품 개발자에게 있어 가장 큰 과제는 IMiD 골격을 기반으로, 사리도마이드의 기형 유발과 관련이 있는 것으로 여겨지는 바람직하지 않은 약리학적 특성을 남기지 않으면서, 대체 네오 기질을 모집하는 새로운 분자 접착제를 설계하는 것입니다. 2025년 'Nature Communications'에 게재된 연구에 따르면, IMiD 유사 분자가 존재하는 조건에서 290개 이상의 표적이 CRBN에 결합하여 분해되는 것이 확인되었습니다. 따라서 IMiD 유도체는 확립된 약리학적 특성을 지닌 귀중한 연구용 프로브이며, 분자 접착제의 창출 및 신약 개발에서의 발견 수단으로서 분자 접착제 연구를 추진하기 위한 풍부한 영감의 원천이라고 할 수 있습니다.

DCAF15를 기반으로 하는 글루로는 인디슬람(Indisram) 등의 화합물이 있습니다. 이들은 분자 접착제로서 기능하며, 서로 다른 CRL4 어댑터를 RBM39에 모집함으로써 분자 접착제의 기능이 세레브론에 의존하지 않음을 입증하고 있습니다. CRBN 기반 프로그램이 가장 많은 임상적으로 검증된 사례를 제공해 왔지만, 분자 접착제에 대한 새로운 접근 방식은 조직 특이적 결합, 새로운 생물학적 특성 및 메커니즘, 그리고 서로 다른 내성 패턴을 제공하는 대체 E3 리가제 표적을 제시하는 것을 목표로 하고 있습니다. 또한, 새롭게 부상하고 있는 접근 방식 중에는 유도된 근접성을 활용하여 새로운 모집 메커니즘을 활성화하는 방법이 있습니다. 2025년 미국임상종양학회(ASCO) 연례 총회에서 몬테 로사(Monte Rosa)는 자사의 분자 접착제 화합물 컬렉션에 특정 E3 리가아제에 높은 친화력으로 결합하는 1,000종 이상의 독자적인 저분자량 스캐폴드가 포함되어 있다고 발표했습니다. 이는 분자 접착제 분야에서의 경쟁이 개별 화합물에서 화합물 컬렉션으로 이동하고 있음을 보여주며, 이를 통해 난제가 많은 E3 리가아제에 대한 분자 접착제 조절제의 발굴이 가속화될 것으로 기대됩니다.

분자 접착제 시장 - 지역별 인사이트

발전된 생명공학 및 제약 부문은 벤처 캐피털의 지원을 받는 신약 개발 및 제휴 계약, 첨단 단백질체학 역량, 주요 지원 기관 및 규제 당국과의 근접성을 제공함으로써 분자 접착제 치료제의 혁신 기업과 신생 기업을 가장 많이 배출하고 있습니다. 보스턴 및 더 광범위한 미국의 혁신 허브에서 나온 성과는 의약 화학, 구조 생물학, 임상 연구를 결합함으로써 분자 접착제 분해제의 중개 신약 개발 주기를 단축하고 있습니다. 몬테 로사(Monte Rosa)는 2025년 기준 150명의 정규직 직원을 보유하고 있으며, 이 중 118명이 조사개발 활동에 종사하고 있다고 보고하고 있습니다. 이는 해당 분야의 과학 전문가들이 현저하게 집적된 데 힘입어, 이 회사가 연구 및 신약 개발에 집중하고 있음을 여실히 보여줍니다. 이 지역이 분자 접착제 치료제 신약 개발을 신속하게 추진할 수 있는 능력은 의심할 여지 없이 매력적이지만, 그 매력은 제조에 관한 전문 지식이나 역량과는 직접적인 관련이 없습니다.

유럽의 경쟁 우위는 제약 연구, 단백질 분해에 관한 학술적 전문 지식, 그리고 독일, 영국, 스위스 및 기타 유럽 국가들 간의 협력 관계에 의해 뒷받침되고 있습니다. 에보텍이 함부르크를 거점으로 브리스톨-마이어스 스퀴브사와 맺고 있는 ‘분자 접착제’ 관련 제휴에서는 멀티오믹스 스크리닝,AI를 활용한 데이터 분석, CELMoD 화합물 화학이 모색되고 있으며, 이는 제약 기업의 연구개발 부서 이외의 영역에서도 유럽이 신약 개발을 어떻게 지원하고 있는지를 보여줍니다. 이 회사는 2025년 기준으로 4,800명 이상의 자격을 갖춘 전문가를 고용하고 있으며, 유럽과 미국 양쪽에 상호 보완적인 기술 클러스터를 보유함으로써 연구를 위한 견고한 산업 기반을 제공하고 있습니다. 유럽의 강점은 기업의 신약 개발 활동을 강화하는 연구 파트너십, 플랫폼 및 전문적인 스크리닝 역량을 통해 확립되어 있습니다.

목차

제1장 분자 접착제 시장 개요

제2장 주요 요약

제3장 분자 접착제 주요 시장 동향

제4장 분자 접착제 산업 분석

제5장 분자 접착제 시장 : 높아지는 지정학적 긴장의 영향

제6장 분자 접착제 시장 구도

제7장 분자 접착제 시장 : 제품별

제8장 분자 접착제 시장 : 용도별

제9장 분자 접착제 시장 : 유형별

제10장 분자 접착제 시장 : 최종사용자별

제11장 분자 접착제 시장 : 지역별

제12장 주요 벤더 분석 : 분자 접착제 산업

제13장 AnalystView의 전방위 전망

KSM 26.08.26

Molecular Glues Market size was valued at US$ 4,200.3 Million in 2025, expanding at a CAGR of 6.9% from 2026 to 2033.

Molecular glues are small molecules that bind to E3 ubiquitin ligases and divert them to different protein substrates to induce ubiquitination and degradation. Established commercial players are built around immune-modulating imide agents, such as lenalidomide, thalidomide and pomalidomide, whereas discovery phase molecules are focused on CRBN, DCAF15, and recently, developing target and pathway-based ligases. Commercialization efforts are led by Oncology, with Immunology and additional disease areas broadening opportunity space. The study published in Nature Communications in 2025 demonstrated that IMiDs recruit more than 290 unique proteins to CRBN, including several beyond the established list of targets. As a result, there is a growing demand in such tools, including platform discovery, selectivity, and clinically relevant degradation mechanisms.

Molecular Glues Market- Market Dynamics

Expanding the Traditionally Difficult-to-Drug Protein Space

A prime market differentiator is the capacity of molecular glues to engage challenging proteins as degraders rather than inhibitors by harnessing cooperative protein interactions that enable smaller molecules to direct endogenous ubiquitin ligases with minimal requirements for a ligandable pocket on the target. This creates fundamentally different discovery economics that favor phenotypic screening campaigns, proteomic analyses, structural biology, and AI-driven substrate discovery. At least 1,600 different proteins have been amenable to seizing cereblon based on in silico analysis performed by Monte Rosa in 2025 using its QuEEN discovery engine, suggesting significant target space diversity for molecular glue degraders. Thus, it becomes clear that discovery platforms that can identify selective neosubstrates will define pipelines.

Molecular Glues Market- Segmentation Analysis:

The Global Molecular Glues Market is segmented on the basis of Product, Application, Type, End User, and Region.

Lenalidomide, thalidomide, and pomalidomide are the key product segments, as their clinical validation demonstrated the value of cereblon-mediated degradation as a therapeutic modality. Lenalidomide and pomalidomide are the preferred lead compounds for the development of the next generation of degrader molecules due to the significant potential for generating molecular glue liabilities similar to lenalidomide. However, thalidomide remains an important reference compound that serves as the basis for describing mechanisms of action. The biggest challenge for product developers is to engineer novel molecular glues based on IMiDs' scaffolds that recruit alternative neosubstrates without retaining undesirable pharmacology that has been implicated in thalidomide teratogenicity. The research published in Nature Communications in 2025 confirmed that more than 290 targets could be recruited to bind to CRBN and undergo degradation in the presence of IMiD-like molecules. Thus, it can be concluded that the IMiD derivatives represent valuable research probes with well-established pharmacology and a rich source of inspiration for creating molecular glues and advancing molecular glue research as a discovery modality in drug discovery.

DCAF15-based glues are exemplified by compounds such as indisulam that act as molecular glue to recruit a different CRL4 adaptor onto RBM39, thereby demonstrating that molecular glue function does not rely on cereblon. While programs based on CRBN have provided the most clinically validated examples, new approaches to molecular glue seek to provide alternative E3 ligase targets that will offer tissue-specific engagement, new biology and mechanisms, and different resistance patterns. Additional emerging approaches provide ways to harness induced proximity to engage new recruitment mechanisms. At the 2025 American Society of Clinical Oncology Annual Meeting, Monte Rosa stated that its molecular glue compound collection includes over one thousand unique low molecular weight scaffolds with high-affinity binding to specific E3 ligases. This highlights the shift in competition in the molecular glue space from individual compounds to compound collections to accelerate the discovery of molecular glue modulators of challenging E3 ligases.

Molecular Glues Market- Geographical Insights

A developed biotechnology and pharmaceutical sector drive the most significant number of molecular glue therapeutics innovators and start-ups offering venture backed discovery and partnering deals, advanced proteomic capabilities, and proximity to key enablers and regulators. The readouts from Boston and the broader U.S. innovation hubs shorten the translational drug discovery cycle for molecular glue degraders, linking together medicinal chemistry, structural biology, and clinical research. Monte Rosa reported having 150 full-time employees, including 118 engaged in research and development activities, as of 2025, highlighting the company's research and discovery focus, which is driven by a significant concentration of scientific experts within the field. While the region's capacity to rapidly advance molecular glue therapeutics discovery is undeniably compelling, its appeal is not related to manufacturing expertise and capabilities directly.

Europe's competitive edge is driven by pharmaceutical research, academic expertise in protein degradation, and collaborative ties between Germany, the UK, Switzerland, and other European countries. Evotec's Hamburg-based molecular glue partnership with Bristol Myers Squibb is exploring multi-omics screening, AI-driven data analysis, and CELMoD compound chemistry, demonstrating how Europe supports drug discovery outside pharma's corporate R&D. The company employs more than 4,800 qualified professionals as of 2025 and has complementary technology clusters in both Europe and the U.S., providing a strong industrial foundation for research. Europe's strength is positioned due to its research partnerships, platforms, and specialized screening capabilities that enhance corporate drug discovery.

Molecular Glues Market- Competitive Landscape:

The competition takes place through the different areas of involvement. For instance, Bristol Myers Squibb is a leading player in the market due to its extensive expertise in developing cereblon modulated degraders. Monte Rosa focuses on the glue discovery area with the help of an AI-driven rational approach, while C4 Therapeutics leans towards creating clinically differentiated degraders. Moreover, Evotec has industrialized multi-omics and data-driven drug discovery platforms to engage in partnerships. The key advantage of collaboration with pharma companies lies in the opportunity to combine target biology, drug discovery, clinical implementation, and commercialization processes. According to Monte Rosa's report, 71 of its 150 employees earned M.D. or Ph.D. degrees by 2025, which underscores the gap in the area. Competitive positioning is therefore moving toward integrated discovery engines, translational depth, and differentiation.

Recent Developments:

In June 2025, Monte Rosa Therapeutics reported that it cleared the IND application for MRT-8102, a NEK7-targeted molecular glue degrader, thereby advancing a first-in-class E3 ligase- directed molecular glue degrader into clinical studies and expanding the potential applications of molecular glue degraders beyond oncology.

In September 2025, Monte Rosa Therapeutics and Novartis announced a collaboration and a joint research agreement for the discovery and development of degraders of targets involved in immune-mediated diseases. According to the agreement, Novartis received the right to one of the discovery targets and options for two other preclinical immunology programs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MOLECULAR GLUES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Bristol Myers Squibb
  • Novartis AG
  • C4 Therapeutics, Inc.
  • Monte Rosa Therapeutics, Inc.
  • Proxygen GmbH
  • SEED Therapeutics
  • Kymera Therapeutics, Inc.
  • Nurix Therapeutics, Inc.
  • Neomorph, Inc.
  • Evotec SE
  • Roche / Genentech
  • Eli Lilly and Company
  • Pfizer Inc.
  • Arvinas, Inc.
  • Eisai Co., Ltd.
  • Merck & Co., Inc.
  • Boehringer Ingelheim
  • Sanofi
  • Novo Nordisk
  • Takeda Pharmaceutical Company Limited
  • Others

GLOBAL MOLECULAR GLUES MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Lenalidomide
  • Thalidomide
  • Pomalidomide
  • Others

GLOBAL MOLECULAR GLUES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Autoimmune & Inflammatory Diseases
  • Hematologic Malignancies
  • Solid Tumors
  • Neurological & Genetic Diseases
  • Others

GLOBAL MOLECULAR GLUES MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • DCAF15-based Molecular Glues
  • CRBN/Cereblon-based Molecular Glues
  • Novel E3 Ligase-based Molecular Glues
  • Others

GLOBAL MOLECULAR GLUES MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • CROs/Drug Discovery Service Providers
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others

GLOBAL MOLECULAR GLUES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Molecular Glues Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Molecular Glues Market Snippet by Product
    • 2.1.2. Molecular Glues Market Snippet by Application
    • 2.1.3. Molecular Glues Market Snippet by Type
    • 2.1.4. Molecular Glues Market Snippet by End User
    • 2.1.5. Molecular Glues Market Snippet by Country
    • 2.1.6. Molecular Glues Market Snippet by Region
  • 2.2. Competitive Insights

3. Molecular Glues Key Market Trends

  • 3.1. Molecular Glues Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Molecular Glues Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Molecular Glues Market Opportunities
  • 3.4. Molecular Glues Market Future Trends

4. Molecular Glues Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Molecular Glues Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Molecular Glues Market Landscape

  • 6.1. Molecular Glues Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Molecular Glues Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. Lenalidomide
    • 7.1.3. Thalidomide
    • 7.1.4. Pomalidomide
    • 7.1.5. Others

8. Molecular Glues Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Autoimmune & Inflammatory Diseases
    • 8.1.3. Hematologic Malignancies
    • 8.1.4. Solid Tumors
    • 8.1.5. Neurological & Genetic Diseases
    • 8.1.6. Others

9. Molecular Glues Market - By Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 9.1.2. DCAF15-based Molecular Glues
    • 9.1.3. CRBN/Cereblon-based Molecular Glues
    • 9.1.4. Novel E3 Ligase-based Molecular Glues
    • 9.1.5. Others

10. Molecular Glues Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 10.1.2. CROs/Drug Discovery Service Providers
    • 10.1.3. Pharmaceutical & Biotechnology Companies
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Others

11. Molecular Glues Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Molecular Glues Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Molecular Glues Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Molecular Glues Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Molecular Glues Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Molecular Glues Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Molecular Glues Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Bristol Myers Squibb
    • 12.2.2. Novartis AG
    • 12.2.3. C4 Therapeutics, Inc.
    • 12.2.4. Monte Rosa Therapeutics, Inc.
    • 12.2.5. Proxygen GmbH
    • 12.2.6. SEED Therapeutics
    • 12.2.7. Kymera Therapeutics, Inc.
    • 12.2.8. Nurix Therapeutics, Inc.
    • 12.2.9. Neomorph, Inc.
    • 12.2.10. Evotec SE
    • 12.2.11. Roche / Genentech
    • 12.2.12. Eli Lilly and Company
    • 12.2.13. Pfizer Inc.
    • 12.2.14. Arvinas, Inc.
    • 12.2.15. Eisai Co., Ltd.
    • 12.2.16. Merck & Co., Inc.
    • 12.2.17. Boehringer Ingelheim
    • 12.2.18. Sanofi
    • 12.2.19. Novo Nordisk
    • 12.2.20. Takeda Pharmaceutical Company Limited
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기